RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
West Nile Virus Global Clinical Trials Review, Q1, 2011
Apr 2011 - 24 pages - $1,000
Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use
Feb 2011 - 26 pages - $5,700
Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow
May 2011 - 6 pages - $500
Forecast Insight: HIV – Increasing dominance of fixed dose combinations raises bar for single agents
Jun 2010 - 126 pages - $15,200
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
West Nile Virus Infections - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
West Nile Virus Infections - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
May 2009 - 131 pages - $3,800
Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010
Dec 2010 - 48 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Pediatric del
Therapeutic target
Infectious diseases del
Bacteria or virus del
Human papilloma virus del
Development phase
Preclinical del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us